A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury

• Pavel I. Pilipenko,
• Anna A. Ivanova,
• Yulia V. Kotsiubinskaya,
• Vera N. Grigoryeva,
• Alexey Y. Khrulev,
• Anatoly V. Skorokhodov,
• Maxim M. Gavrik,
• Nona N. Mkrtchan,
• Marek Majdan,
• Peter Valkovic,
• Daria Rabarova,
• Suzanne Barker-Collo,
• Kelly Jones,
• Valery L. Feigin

Affiliations

Pavel I. Pilipenko

Anna A. Ivanova

Yulia V. Kotsiubinskaya

Vera N. Grigoryeva

Alexey Y. Khrulev

Anatoly V. Skorokhodov

Maxim M. Gavrik

Nona N. Mkrtchan

Marek Majdan

Peter Valkovic

Daria Rabarova

Suzanne Barker-Collo

Kelly Jones

Valery L. Feigin